Johnson & Johnson ordered to pay US$260-million in latest talc trial

Johnson & Johnson must pay US$260-million to an Oregon woman who said she developed a deadly cancer linked to asbestos exposure, from inhaling the company's talc powder, a jury found on June 3.

Reuters